A detailed history of V2 Financial Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, V2 Financial Group LLC holds 24,600 shares of PFE stock, worth $702,822. This represents 0.51% of its overall portfolio holdings.

Number of Shares
24,600
Previous 24,630 0.12%
Holding current value
$702,822
Previous $683 Million 10.57%
% of portfolio
0.51%
Previous 0.47%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$25.26 - $29.6 $757 - $888
-30 Reduced 0.12%
24,600 $756 Million
Q1 2024

May 09, 2024

BUY
$25.89 - $29.73 $637,670 - $732,249
24,630 New
24,630 $683 Million
Q3 2023

May 10, 2024

BUY
$32.09 - $37.51 $93,061 - $108,779
2,900 Added 32.66%
11,780 $391 Million
Q1 2023

May 10, 2024

SELL
$39.39 - $51.28 $620,392 - $807,660
-15,750 Reduced 63.95%
8,880 $362 Million
Q4 2022

May 10, 2024

BUY
$41.75 - $54.5 $2,505 - $3,270
60 Added 0.64%
9,480 $486 Million
Q2 2022

May 10, 2024

SELL
$46.53 - $55.17 $1.78 Million - $2.11 Million
-38,198 Reduced 80.22%
9,420 $494 Million
Q1 2022

May 10, 2024

SELL
$45.75 - $56.69 $388,966 - $481,978
-8,502 Reduced 15.15%
47,618 $2.47 Billion
Q4 2021

May 10, 2024

BUY
$41.32 - $61.25 $17,932 - $26,582
434 Added 0.78%
56,120 $3.31 Billion
Q3 2021

May 10, 2024

BUY
$39.25 - $50.42 $1.22 Million - $1.57 Million
31,056 Added 126.09%
55,686 $2.4 Billion
Q2 2021

May 10, 2024

BUY
$35.91 - $40.68 $1.65 Million - $1.87 Million
45,966 Added 470.87%
55,728 $2.18 Billion
Q1 2021

May 10, 2024

BUY
$33.49 - $37.77 $28,868 - $32,557
862 Added 9.69%
9,762 $354 Million
Q4 2020

May 10, 2024

SELL
$33.47 - $42.56 $526,483 - $669,468
-15,730 Reduced 63.87%
8,900 $328 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track V2 Financial Group LLC Portfolio

Follow V2 Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of V2 Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on V2 Financial Group LLC with notifications on news.